GSK Vaccine Recall: Flulaval “Might Cause More Harm Than Good”

“due to effectiveness issues”. They did not work but were they safe?

sentinelblog

Source: Occupy Corporatism, By Susanne Posel

Susanne.Posel-Headline.News.Official- flulaval.glaxosmithklein.ineffective.recall_occupycorporatism

GlaxoSmithKline (GSK) have ordered a recall of their 4 in 1 vaccine called Flulaval Quadrivalent Thimerosal “due to effectiveness issues”.

GSK said “the vaccine might cause more harm than good because it is not good enough to protect someone from the current flu strains present in the US.”

Flulaval “was designed” to protect against Type A and B and 2 other flu strains which makes it a quadrivalent vaccine – the new standard in inoculations.

GSK admitted in a statement “[we] cannot rule out prospective suboptional protection” for those who received Flulaval in early January of this year or later.

This information was disseminated in a letter to GSK clients such as wholesale distributors, pharmacies, government agencies and physicians in the US.

Because Flulaval is ineffective, 1.7 million doses are being recalled while GSK conducts testing on the product to prove efficiency.

Anna Padula…

View original post 65 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s